Screening for Liver Disease in Type 2
![](https://www.diabetesnews.com/wp-content/uploads/2017/08/iStock_000012888324_Smallliver-150x150.jpg)
Non-alcoholic fatty liver disease (NAFLD) originates from fat accumulation in the liver and can potentially lead to scarring of the tissue, cirrhosis, and liver cancer. It is known as a component of metabolic syndrome, which is often related to type 2 diabetes. Currently, there are no recommendations for standard NAFLD screenings in people with type […]